Biohaven Ltd. financial data

Symbol
BHVN on NYSE
Industry
Pharmaceutical Preparations
Location
215 Church Street, New Haven, Connecticut
State of incorporation
Virgin Islands, British
Fiscal year end
December 31
Former names
Biohaven Research Ltd. (to 9/14/2022)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 526 %
Debt-to-equity 29.5 %
Return On Equity -147 % +23.2%
Return On Assets -114 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 81.6 M shares +19.6%
Common Stock, Shares, Outstanding 81.8 M shares +19.9%
Entity Public Float 987 M USD
Common Stock, Value, Issued 911 M USD +47.8%
Weighted Average Number of Shares Outstanding, Basic 81.6 M shares +19.6%
Weighted Average Number of Shares Outstanding, Diluted 81.6 M shares +19.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 466 M USD +8.21%
General and Administrative Expense 75.7 M USD -39.7%
Costs and Expenses 542 M USD -2.6%
Operating Income (Loss) -542 M USD +2.6%
Nonoperating Income (Expense) 26.5 M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -519 M USD +5.58%
Income Tax Expense (Benefit) -1.75 M USD +70.2%
Net Income (Loss) Attributable to Parent -517 M USD +4.89%
Earnings Per Share, Basic -6.9 USD/shares +39%
Earnings Per Share, Diluted -6.9 USD/shares +39%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 183 M USD +46.1%
Marketable Securities, Current 101 M USD -61.7%
Other Assets, Current 10.7 M USD -56.7%
Assets, Current 349 M USD -35.9%
Property, Plant and Equipment, Net 16.7 M USD -4.58%
Operating Lease, Right-of-Use Asset 30.9 M USD -9.26%
Intangible Assets, Net (Excluding Goodwill) 18.4 M USD 0%
Goodwill 1.39 M USD 0%
Other Assets, Noncurrent 33.3 M USD -9.4%
Assets 419 M USD -32.3%
Accounts Payable, Current 36.4 M USD +152%
Employee-related Liabilities, Current 5.39 M USD +25.1%
Accrued Liabilities, Current 50.2 M USD +32.1%
Liabilities, Current 86.6 M USD -24.1%
Operating Lease, Liability, Noncurrent 27.1 M USD -8.99%
Other Liabilities, Noncurrent 3.41 M USD +36.6%
Liabilities 117 M USD -19.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -106 K USD -164%
Retained Earnings (Accumulated Deficit) -679 M USD -320%
Stockholders' Equity Attributable to Parent 301 M USD -36.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 539 M USD +1453%
Liabilities and Equity 419 M USD -32.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -103 M USD -32.2%
Net Cash Provided by (Used in) Financing Activities 3.42 M USD -87.2%
Net Cash Provided by (Used in) Investing Activities 34 M USD
Common Stock, Shares Authorized 200 M shares 0%
Common Stock, Shares, Issued 81.8 M shares +19.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -65.2 M USD -25.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 187 M USD -1.92%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 259 M USD +20.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0 pure
Operating Lease, Liability 30.9 M USD -8.1%
Depreciation 3.55 M USD +85.1%
Payments to Acquire Property, Plant, and Equipment 440 K USD -40.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -517 M USD +4.81%
Lessee, Operating Lease, Liability, to be Paid 39.8 M USD -10.8%
Operating Lease, Liability, Current 3.45 M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.78 M USD -4%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.02 M USD +1.85%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.9 M USD -18.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.91 M USD +3.44%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) -1.38 M USD -416%
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 2.2 M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.51 M USD -7.32%
Operating Lease, Payments 4.85 M USD +522%
Additional Paid in Capital 69.4 M USD +297%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.45 M USD -12.3%
Deferred Tax Assets, Net of Valuation Allowance 7.52 M USD +1061%
Share-based Payment Arrangement, Expense 1.34 M USD